logo

YCBD

cbdMD·AMEX
--
--(--)
--
--(--)
1.06 / 10
Underperform

Fundamental scrutiny indicates cbdMD is in poor standing with key metrics such as ROA (%) and net profit margin posting negative values around -19.4 and -10.6 respectively. Only the Asset-MV and Quick ratio factors show marginally favorable readings, yet they are insufficient to offset the overall weakness. Historical back-tests for these factors also predict negative monthly returns, reinforcing the underperform classification.

Fundamental(1.06)SentimentTechnical

Analysis Checks(2/10)

ROA (%)
Value-19.44
Score1/3
Weight5.76%
1M Return-4.34%
Net assets per share (growth rate compared to beginning of year %)
Value62.96
Score0/3
Weight12.68%
1M Return-7.88%
Net cash flow from operating activities / Operating revenue (%)
Value-7.57
Score0/3
Weight14.35%
1M Return-10.71%
Quick ratio
Value1.13
Score2/3
Weight5.44%
1M Return-2.90%
Profit-MV
Value0.47
Score0/3
Weight18.17%
1M Return-12.99%
Net profit margin (%)
Value-10.63
Score1/3
Weight7.37%
1M Return-4.05%
Annualized net profit margin on total assets (%)
Value-19.44
Score1/3
Weight5.76%
1M Return-4.34%
Net profit / Total operating revenue (%)
Value-10.63
Score1/3
Weight7.37%
1M Return-4.05%
Asset-MV
Value-0.51
Score2/3
Weight7.20%
1M Return-4.63%
Cash-MV
Value-0.07
Score0/3
Weight15.90%
1M Return-13.44%
Is YCBD fundamentally strong?
  • YCBD scores 1.06/10 on fundamentals and holds a Premium valuation at present. Backed by its -95.23% ROE, -10.63% net margin, -2.21 P/E ratio, 1.34 P/B ratio, and 92.37% earnings growth, these metrics solidify its Underperform investment rating.